NOS2 and leishmaniasis: This immunomodulation induced by the native molecule and the synthetic analogs is likely to affect the clinical outcome of leishmaniasis, since M1 macrophages produce inducible nitric oxide synthase, iNOS, which converts L-arginine to NO and mediates to parasite killing.